1.20
-0.085(-6.64%)
Currency In USD
| Previous Close | 1.28 |
| Open | 1.3 |
| Day High | 1.3 |
| Day Low | 1.18 |
| 52-Week High | 4.23 |
| 52-Week Low | 1.16 |
| Volume | 8.48M |
| Average Volume | 11.3M |
| Market Cap | 327.27M |
| PE | -0.76 |
| EPS | -1.58 |
| Moving Average 50 Days | 1.63 |
| Moving Average 200 Days | 1.75 |
| Change | -0.09 |
If you invested $1000 in Pacific Biosciences of California, Inc. (PACB) 10 years ago, it would be worth $203.92 as of March 13, 2025 at a share price of $1.195. Whereas If you bought $1000 worth of Pacific Biosciences of California, Inc. (PACB) shares 5 years ago, it would be worth $391.8 as of March 13, 2025 at a share price of $1.195.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
PacBio to Participate in TD Cowen's 45th Annual Health Care Conference
GlobeNewswire Inc.
Feb 19, 2025 9:05 PM GMT
MENLO PARK, Calif., Feb. 19, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be presenting at TD Cowen's 45th Annual Health Care Confere
PacBio Announces Appointment of David Ruggiero as Head of Global Sales & Service
GlobeNewswire Inc.
Feb 03, 2025 2:05 PM GMT
MENLO PARK, Calif., Feb. 03, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the appointment of David Ruggiero as the company’s new Global Head of Sales & Se
PacBio to Report Fourth Quarter 2024 Financial Results on February 13, 2025
GlobeNewswire Inc.
Jan 30, 2025 9:05 PM GMT
MENLO PARK, Calif., Jan. 30, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its fourth quarter 2024 financial results on Thursday, February 13, 2025, at 4:30 pm Eastern Time